PELTANOVÁ, Barbora, Markéta LIŠKOVÁ, Jaromír GUMULEC, Martina RAUDENSKÁ, Hana HOLCOVÁ POLANSKÁ, Tomáš VACULOVIČ, David KALFERT, Marek GREGA, Jan PLZAK, Jan BETKA and Michal MASAŘÍK. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences. Basel: MDPI, 2021, vol. 22, No 4, p. 1-13. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms22041912.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts
Authors PELTANOVÁ, Barbora (203 Czech Republic, belonging to the institution), Markéta LIŠKOVÁ (203 Czech Republic, belonging to the institution), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Martina RAUDENSKÁ (203 Czech Republic, belonging to the institution), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Tomáš VACULOVIČ (203 Czech Republic, belonging to the institution), David KALFERT (203 Czech Republic), Marek GREGA (203 Czech Republic), Jan PLZAK (203 Czech Republic), Jan BETKA (203 Czech Republic) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition International Journal of Molecular Sciences, Basel, MDPI, 2021, 1422-0067.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.208
RIV identification code RIV/00216224:14110/21:00119149
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/ijms22041912
UT WoS 000623863700001
Keywords in English head and neck cancer; cancer-associated fibroblasts; cisplatin; treatment resistance; cancer recurrence; patient-derived cell cultures; coculture
Tags 14110515, 14110518, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2022 13:42.
Abstract
Cancer-associated fibroblasts (CAFs) are one of the most abundant and critical components of the tumor stroma. CAFs can impact many important steps of cancerogenesis and may also influence treatment resistance. Some of these effects need the direct contact of CAFs and cancer cells, while some involve paracrine signals. In this study, we investigated the ability of head and neck squamous cell carcinomas (HNSCC) patient-derived CAFs to promote or inhibit the colony-forming ability of HNSCC cells. The effect of cisplatin on this promoting or inhibiting influence was also studied. The subsequent analysis focused on changes in the expression of genes associated with cancer progression. We found that cisplatin response in model HNSCC cancer cells was modified by coculture with CAFs, was CAF-specific, and different patient-derived CAFs had a different "sensitizing ratio". Increased expression of VEGFA, PGE2S, COX2, EGFR, and NANOG in cancer cells was characteristic for the increase of resistance. On the other hand, CCL2 expression was associated with sensitizing effect. Significantly higher amounts of cisplatin were found in CAFs derived from patients who subsequently experienced a recurrence. In conclusion, our results showed that CAFs could promote and/or inhibit colony-forming capability and cisplatin resistance in HNSCC cells via paracrine effects and subsequent changes in gene expression of cancer-associated genes in cancer cells.
Links
GA18-03978S, research and development projectName: Efekt buněčné tuhosti a mikroprostředí jako prediktor odpovědi na léčbu karcinomů hlavy a krku
Investor: Czech Science Foundation
MUNI/A/1246/2020, interní kód MUName: Kardiovaskulární systém: od iontového kanálu k celotělovému modelu (Acronym: KAVASYKAMO)
Investor: Masaryk University
MUNI/A/1698/2020, interní kód MUName: Od molekulární, buněčné a tkáňové k systémové patofyziologii vybraných komplexních nemocí (Acronym: ComplexPF)
Investor: Masaryk University
NV18-08-00229, research and development projectName: Interakce buněk nádorového mikroprostředí jako nový nástroj predikce účinnosti terapie nádorů hlavy a krku
Investor: Ministry of Health of the CR
ROZV/28/LF25/2020, interní kód MUName: Odhaleni vlivu metabolické symbiózy a fibroblastů asociovaných s nádorem na invazívitu a migračnl potenciál HNSCC buněčných linii
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 24/4/2024 18:58